Skip to main content

Articles

Page 7 of 18

  1. Urine drug monitoring for medications for opioid use disorder (MOUD) such as buprenorphine can help to support treatment adherence. The practice of introducing unconsumed medication directly into urine (known ...

    Authors: Jill S. Warrington, Kaitlyn Booth, Gregory S. Warrington and Samuel Francis-Fath
    Citation: Addiction Science & Clinical Practice 2020 15:3
  2. If Russia is to achieve the UNAIDS 90-90-90 HIV targets, better approaches to engage, effectively treat, and retain patients in care are needed. This paper describes the protocol of a randomized controlled tri...

    Authors: Natalia Gnatienko, Dmitry Lioznov, Anita Raj, Elena Blokhina, Sydney Rosen, Debbie M. Cheng, Karsten Lunze, Sally Bendiks, Ve Truong, Natalia Bushara, Olga Toussova, Emily Quinn, Evgeny Krupitsky and Jeffrey H. Samet
    Citation: Addiction Science & Clinical Practice 2020 15:1
  3. Group-Based Opioid Treatment (GBOT) has recently emerged as a mechanism for treating patients with opioid use disorder (OUD) in the outpatient setting. However, the more practical “how to” components of succes...

    Authors: Randi Sokol, Mark Albanese, Aaronson Chew, Jessica Early, Ellie Grossman, David Roll, Greg Sawin, Dominic J. Wu and Zev Schuman-Olivier
    Citation: Addiction Science & Clinical Practice 2019 14:47
  4. The integration of opioid use disorder (OUD) care and competencies in graduate medical education training is needed. Previous research shows improvements in knowledge, attitudes, and practices after exposure t...

    Authors: Jarratt D. Pytell, Megan E. Buresh and Ryan Graddy
    Citation: Addiction Science & Clinical Practice 2019 14:46
  5. It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infectio...

    Authors: Thomas R. Blue, Michael S. Gordon, Robert P. Schwartz, Kathryn Couvillion, Frank J. Vocci, Terrence T. Fitzgerald and Kevin E. O’Grady
    Citation: Addiction Science & Clinical Practice 2019 14:45
  6. Cannabis use has become increasingly common in the U.S. in recent years, with legalization for medical and recreational purposes expanding to more states. With this increase in use and access, providers should...

    Authors: Devan Kansagara, William C. Becker, Chelsea Ayers and Jeanette M. Tetrault
    Citation: Addiction Science & Clinical Practice 2019 14:42
  7. Internet interventions have been developed and tested for several psychiatric and somatic conditions. Few people with substance use disorders receive treatment and many drug users say that they would prefer ge...

    Authors: Veronica Ekström and Magnus Johansson
    Citation: Addiction Science & Clinical Practice 2019 14:44
  8. For people living with HIV/AIDS (PLWHA), alcohol consumption is associated with poor treatment outcomes and medication adherence. This pilot study examined the feasibility of using smartphones and mobile Bluet...

    Authors: Carolyn Lauckner, Erica Taylor, Darshti Patel and Alexis Whitmire
    Citation: Addiction Science & Clinical Practice 2019 14:43
  9. Dependence to prescription and over-the-counter (OTC) drugs represents an increasing public health and clinical problem both in England and internationally. However, relatively little is known about those affe...

    Authors: Heidi Coombes and Richard J. Cooper
    Citation: Addiction Science & Clinical Practice 2019 14:41
  10. For more than 30 years, drug consumption rooms (DCRs) have been implemented in Western countries. DCRs are supported by a large body of evidence about public safety and public health effectiveness. However, a ...

    Authors: Pierre Smith, Louis Favril, Dominique Delhauteur, Freya Vander Laenen and Pablo Nicaise
    Citation: Addiction Science & Clinical Practice 2019 14:40
  11. The TAPS Tool is a substance use screening and brief assessment instrument that was developed for use in primary care medical settings. It is one of the first screening instruments to provide rapid assessment ...

    Authors: Angéline Adam, Robert P. Schwartz, Li-Tzy Wu, Geetha Subramaniam, Eugene Laska, Gaurav Sharma, Saima Mili and Jennifer McNeely
    Citation: Addiction Science & Clinical Practice 2019 14:39
  12. Tobacco smoking is highest among population groups which are the most socially disadvantaged. Internet-based smoking cessation programs have been found to be effective, though rates of internet access are not ...

    Authors: Sam McCrabb, Laura Twyman, Kerrin Palazzi, Ashleigh Guillaumier, Christine Paul and Billie Bonevski
    Citation: Addiction Science & Clinical Practice 2019 14:38
  13. Few studies have documented patient attitudes and experiences with extended-release naltrexone (XR-NTX) opioid relapse prevention in criminal justice settings. This study assessed barriers and facilitators of ...

    Authors: Melissa Velasquez, Mara Flannery, Ryan Badolato, Alexandria Vittitow, Ryan D. McDonald, Babak Tofighi, Ann R. Garment, Jonathan Giftos and Joshua D. Lee
    Citation: Addiction Science & Clinical Practice 2019 14:37
  14. Youth involved in the juvenile justice system (YIJJ) have high rates of substance use problems; however, rates of YIJJ engagement in substance use services is low. Barriers to service engagement include lack o...

    Authors: Matthew C. Aalsma, Allyson L. Dir, Tamika C. B. Zapolski, Leslie A. Hulvershorn, Patrick O. Monahan, Lisa Saldana and Zachary W. Adams
    Citation: Addiction Science & Clinical Practice 2019 14:36
  15. The global rise in opioid-related harms has impacted the United States severely. Current efforts to manage the opioid crisis have prompted a re-evaluation of many of the existing roles in the healthcare system...

    Authors: Paxton Bach and Daniel Hartung
    Citation: Addiction Science & Clinical Practice 2019 14:30
  16. Tobacco use is a chronic relapsing disease, and remains the leading cause of preventable death in much of the world. Increasingly, tobacco use, chiefly cigarette smoking, is being framed as a chronic disease, ...

    Authors: Steven L. Bernstein and Benjamin A. Toll
    Citation: Addiction Science & Clinical Practice 2019 14:29
  17. Chronic pain and heavy drinking commonly co-occur and can influence the course of HIV. There have been no interventions designed to address both of these conditions among people living with HIV (PLWH), and non...

    Authors: Tibor P. Palfai, Jessica L. Taylor, Richard Saitz, Maya P. L. Kratzer, John D. Otis and Judith A. Bernstein
    Citation: Addiction Science & Clinical Practice 2019 14:35
  18. Buprenorphine is a critically important treatment for addressing the opioid epidemic, but there are virtually no studies of physicians’ job satisfaction with providing buprenorphine. Physicians’ job satisfacti...

    Authors: Hannah K. Knudsen, Randy Brown, Nora Jacobson, Julie Horst, Jee-Seon Kim, Elizabeth Collier, Sanford Starr, Lynn M. Madden, Eric Haram, Alexander Toy and Todd Molfenter
    Citation: Addiction Science & Clinical Practice 2019 14:34

    The Commentary to this article has been published in Addiction Science & Clinical Practice 2019 14:33

  19. This study protocol describes a proposed randomized controlled trial that builds upon a successful pilot intervention study to address problematic and dangerous drinking among young adult college students stud...

    Authors: Eric R. Pedersen, Elizabeth J. D’Amico, Joseph W. LaBrie, Coreen Farris, David J. Klein and Beth Ann Griffin
    Citation: Addiction Science & Clinical Practice 2019 14:32
  20. The study examined the association of the Affordable Care Act’s 2014 Medicaid expansion on the use of psychosocial services and pharmacotherapies for opioid use disorders among Oregon Medicaid recipients.

    Authors: Dennis McCarty, Yifan Gu, John W. McIlveen and Bonnie K. Lind
    Citation: Addiction Science & Clinical Practice 2019 14:31
  21. Treating severe emotional dysregulation and co-occurring substance misuse is challenging. Dialectical behaviour therapy (DBT) is a comprehensive and evidence-based treatment for borderline personality disorder...

    Authors: Daniel Flynn, Mary Joyce, Ailbhe Spillane, Conal Wrigley, Paul Corcoran, Aoife Hayes, Marian Flynn, David Wyse, Barry Corkery and Brid Mooney
    Citation: Addiction Science & Clinical Practice 2019 14:28
  22. The continued escalation of opioid use disorder (OUD) calls for heightened vigilance to implement evidence-based care across the US. Rural care providers and patients have limited resources, and a number of ba...

    Authors: Gerald Cochran, Evan S. Cole, Jack Warwick, Julie M. Donohue, Adam J. Gordon, Walid F. Gellad, Todd Bear, David Kelley, Ellen DiDomenico and Jan Pringle
    Citation: Addiction Science & Clinical Practice 2019 14:25
  23. Despite the high prevalence of alcohol use disorders (AUDs), in 2016, only 7.8% of individuals meeting diagnostic criteria received any type of AUD treatment. Developing options for treatment within primary ca...

    Authors: Hildi J. Hagedorn, Jennifer P. Wisdom, Heather Gerould, Erika Pinsker, Randall Brown, Michael Dawes, Eric Dieperink, Donald Hugh Myrick, Elizabeth M. Oliva, Todd H. Wagner and Alex H. S. Harris
    Citation: Addiction Science & Clinical Practice 2019 14:24
  24. North America is in the midst of an opioid overdose epidemic. Although take-home naloxone and other measures have been an effective strategy to reduce overdoses, many events are unwitnessed and mortality remai...

    Authors: Keith Ahamad, Huiru Dong, Cheyenne Johnson, Kanna Hyashi, Kora DeBeck, M. J. Milloy and Evan Wood
    Citation: Addiction Science & Clinical Practice 2019 14:23
  25. Alcohol consumption among Indigenous Australians can involve a stop-start pattern of drinking, with consumption well above recommended guidelines on each occasion. Such intermittent drinking patterns can make ...

    Authors: K. S. Kylie Lee, James H. Conigrave, Scott Wilson, Jimmy Perry, Sarah Callinan, Robin Room, Tanya N. Chikritzhs, Tim Slade, Noel Hayman, Geoffrey Leggat and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2019 14:22
  26. HIV care providers often serve as the specialist and the primary care point-of-contact for persons living with HIV (PLWH) and unhealthy alcohol use. The purpose of the present qualitative study was to understa...

    Authors: Natalie E. Chichetto, Zachary L. Mannes, Megan K. Allen, Robert L. Cook and Nicole Ennis
    Citation: Addiction Science & Clinical Practice 2019 14:21
  27. Opioid overdose is a leading cause of death in persons experiencing homelessness (PEH), despite effective medications for opioid use disorder (OUD). In 2016, the San Francisco Street Medicine Team piloted a lo...

    Authors: Jamie Carter, Barry Zevin and Paula J. Lum
    Citation: Addiction Science & Clinical Practice 2019 14:20
  28. Primary care provider skills such as screening, longitudinal monitoring, and medication management are generalizable to prescribing alcohol use disorder (AUD) pharmacotherapy. The association between primary c...

    Authors: Paul J. Joudrey, Mat Kladney, Chinazo O. Cunningham and Marcus A. Bachhuber
    Citation: Addiction Science & Clinical Practice 2019 14:19
  29. Ontario patients on opioid agonist treatment (OAT) are often prescribed methadone instead of buprenorphine, despite the latter’s superior safety profile. Ontario OAT providers were surveyed to better understan...

    Authors: Anita Srivastava, Meldon Kahan, Pamela Leece and Alison McAndrew
    Citation: Addiction Science & Clinical Practice 2019 14:18
  30. Alcohol consumption among Indigenous Australians can be irregular, depending on social and geographic context. The Finnish method uses the last four drinking occasions to estimate drinking quantity and pattern...

    Authors: K. S. Kylie Lee, James H. Conigrave, Sarah Callinan, Scott Wilson, Robin Room, Jimmy Perry, Tim Slade, Tanya N. Chikritzhs, Noel Hayman, Teagan Weatherall, Geoffrey Leggat, Dennis Gray and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2019 14:15
  31. Post-release opioid-related overdose mortality is the leading cause of death among people released from jails or prisons (PRJP). Informed by the proximate determinants framework, this paper presents the Post-R...

    Authors: Paul J. Joudrey, Maria R. Khan, Emily A. Wang, Joy D. Scheidell, E. Jennifer Edelman, D. Keith McInnes and Aaron D. Fox
    Citation: Addiction Science & Clinical Practice 2019 14:17
  32. Alcohol use in HIV infected patients is associated with risky sexual behaviour, poor adherence to Highly Active Antiretroviral Therapy, treatment failure and increased physiologic harm. The objectives of the s...

    Authors: Munyaradzi Madhombiro, Bazondlile Dube, Michelle Dube, Moleen Zunza, Dixon Chibanda, Simbarashe Rusakaniko and Soraya Seedat
    Citation: Addiction Science & Clinical Practice 2019 14:16
  33. Women recently released from incarceration have increased rates of co-occurring substance use, physical health, and mental health disorders. During re-entry, they face challenges navigating needed health servi...

    Authors: Katherine Thomas, John L. Wilson, Precious Bedell and Diane S. Morse
    Citation: Addiction Science & Clinical Practice 2019 14:12
  34. Tobacco use and heavy episodic drinking (HED) commonly co-occur in young adults. We developed and tested usability of the Smoking Tobacco and Drinking (STAND) intervention for young adults delivered on Facebook.

    Authors: Danielle E. Ramo, Meredith C. Meacham, Manpreet Kaur, Ella S. Corpuz, Judith J. Prochaska and Derek D. Satre
    Citation: Addiction Science & Clinical Practice 2019 14:14
  35. A substantial increase in substance treatment episodes for methamphetamine problems suggests characteristics of the treatment population could have changed and that targeted treatment programs are required. To...

    Authors: Julaine Allan, Ryan H. L. Ip, Michael Kemp and Nicole Snowdon
    Citation: Addiction Science & Clinical Practice 2019 14:13
  36. Buprenorphine effectively reduces opioid craving and illicit opioid use. However, some patients may not take their medication as prescribed and thus experience suboptimal outcomes. The study aim was to qualita...

    Authors: Margo E. Godersky, Andrew J. Saxon, Joseph O. Merrill, Jeffrey H. Samet, Jane M. Simoni and Judith I. Tsui
    Citation: Addiction Science & Clinical Practice 2019 14:11
  37. Swedish national guidelines recommend that all health care settings systematically screen patients for alcohol use and illicit substance use. When hazardous use is identified, it should immediately be addresse...

    Authors: Christopher Sundström, Elisabeth Petersén, Kristina Sinadinovic, Peter Gustafsson and Anne H. Berman
    Citation: Addiction Science & Clinical Practice 2019 14:10
  38. Women experiencing incarceration (WEI) engage in high rates of sex- and drug-related behavior that places them at risk for HIV. Pre-exposure prophylaxis (PrEP) is an efficacious means of reducing HIV acquisiti...

    Authors: Susan E. Ramsey, Evan G. Ames, Lauren Brinkley-Rubinstein, Anne M. Teitelman, Jennifer Clarke and Clair Kaplan
    Citation: Addiction Science & Clinical Practice 2019 14:8
  39. More than 80% of people in jail or prison report having used illicit substances in their lifetimes. After release from incarceration, resumption of substance use carries risks, including parole revocation, exa...

    Authors: Adam Chamberlain, Sylviah Nyamu, Jenerius Aminawung, Emily A. Wang, Shira Shavit and Aaron D. Fox
    Citation: Addiction Science & Clinical Practice 2019 14:7
  40. Treatment for opioid use disorder (OUD) is highly effective, yet it remains dramatically underutilized. Individuals with OUD have disproportionately high rates of hospitalization and low rates of addiction tre...

    Authors: Jennifer McNeely, Andrea B. Troxel, Hillary V. Kunins, Donna Shelley, Joshua D. Lee, Alexander Walley, Zoe M. Weinstein, John Billings, Nichola J. Davis, Roopa Kalyanaraman Marcello, Bruce R. Schackman, Charles Barron and Luke Bergmann
    Citation: Addiction Science & Clinical Practice 2019 14:5
  41. Effective medications for treating alcohol use disorders (AUD) are available but underutilized. Multiple barriers to their provision have been identified, and optimal strategies for addressing and overcoming b...

    Authors: Emily C. Williams, Theresa E. Matson and Alex H. S. Harris
    Citation: Addiction Science & Clinical Practice 2019 14:6
  42. Residential opioid rehabilitation aims to improve the mental health and quality of life of opioid users through abstinence and residential program participation. This study aimed to determine the depression, a...

    Authors: Madeleine M. Southey, Trent Rees, Margaret Rolfe and Sabrina Pit
    Citation: Addiction Science & Clinical Practice 2019 14:4
  43. In Dar es Salaam Tanzania, the first opioid treatment program (OTP) in Sub-Saharan Africa, had very high rates of enrollment of people who use drugs (PWUD) but low rates of antiretroviral therapy (ART) initiat...

    Authors: Alexis Cooke, Haneefa Saleem, Saria Hassan, Dorothy Mushi, Jessie Mbwambo and Barrot Lambdin
    Citation: Addiction Science & Clinical Practice 2019 14:3
  44. Tobacco use remains the leading cause of preventable disease and death in the United States and is concentrated among disadvantaged populations, including individuals with a history of criminal justice involve...

    Authors: Tyler N. A. Winkelman, Katherine Diaz Vickery and Andrew M. Busch
    Citation: Addiction Science & Clinical Practice 2019 14:2
  45. Alcohol use disorder (AUD) and unhealthy drinking are prevalent among women involved in the criminal justice system and women military veterans. Pharmacotherapy—including naltrexone, topiramate, acamprosate, a...

    Authors: Emmeline Taylor, Christine Timko, Alex H. S. Harris, Mengfei Yu and Andrea K. Finlay
    Citation: Addiction Science & Clinical Practice 2019 14:1

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.7
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 1.062
    SCImago Journal Rank (SJR): 1.307

    Speed 2023
    Submission to first editorial decision (median days): 28
    Submission to acceptance (median days): 202

    Usage 2023
    Downloads: 755,413
    Altmetric mentions: 622

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.